The slip
PARKINSON RECEIPTno. 14371
29 Oct 2026, 19:02 UTColigodendrocytes, braak
predictionSCAMP3 in oligodendrocytes tracks Braak Lewy-body stage
registeredf83e9ae95a82253f
discovery+0.46 p=0.209 n=9
replication+0.41 p=0.269 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.46, p 0.209)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTc3dfe991c2178feb23b8be87…
follows 8582ab28d0a1…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 14371: SCAMP3 in oligodendrocytes, braak
- power
- full sample +0.22 (p 0.389, n 18), 95% CI -0.28 to +0.62. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.23 (p 0.351, n 18). does not hold up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: +0.23 (p 0.351, n 18). could be the mix.
- skeptic
- leave-one-out range +0.14 to +0.37, sign flips 0; without severely affected donors +0.22 (p 0.389, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for SCAMP3 in oligodendrocytes.
case closed: nothing better to follow up.